KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Boston Scientific (BSX) Total Current Liabilities (2016 - 2025)

Historic Total Current Liabilities for Boston Scientific (BSX) over the last 17 years, with Q4 2025 value amounting to $5.4 billion.

  • Boston Scientific's Total Current Liabilities fell 1500.23% to $5.4 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $5.4 billion, marking a year-over-year decrease of 1500.23%. This contributed to the annual value of $5.4 billion for FY2025, which is 1500.23% down from last year.
  • Per Boston Scientific's latest filing, its Total Current Liabilities stood at $5.4 billion for Q4 2025, which was down 1500.23% from $5.3 billion recorded in Q3 2025.
  • In the past 5 years, Boston Scientific's Total Current Liabilities registered a high of $6.4 billion during Q4 2024, and its lowest value of $3.4 billion during Q1 2021.
  • Its 5-year average for Total Current Liabilities is $4.7 billion, with a median of $4.6 billion in 2023.
  • Per our database at Business Quant, Boston Scientific's Total Current Liabilities skyrocketed by 3104.89% in 2021 and then tumbled by 1500.23% in 2025.
  • Boston Scientific's Total Current Liabilities (Quarter) stood at $4.3 billion in 2021, then fell by 11.02% to $3.8 billion in 2022, then grew by 29.71% to $4.9 billion in 2023, then grew by 29.72% to $6.4 billion in 2024, then fell by 15.0% to $5.4 billion in 2025.
  • Its Total Current Liabilities was $5.4 billion in Q4 2025, compared to $5.3 billion in Q3 2025 and $5.2 billion in Q2 2025.